Company Profile for Advaxis Incorporated

--(BUSINESS WIRE)--Advaxis is a biotechnology company developing proprietary, live but attenuated Listeria monocytogenes (Listeria) vaccines that deliver engineered tumor antigens, which stimulate multiple, simultaneous immunological mechanisms to fight cancer. Our platform technology was developed by Dr. Yvonne Paterson at The University of Pennsylvania. Today, the Company has over nine (9) distinct, cancer-fighting constructs in various stages of development, directly and through strategic collaborations with such recognized sites of excellence as the City of Hope, the Roswell Park Cancer Institute, the National Cancer Institute, the University of Pittsburgh, Cancer Research – UK, the University of British Columbia and the Department of Homeland Security. Please visit the Company’s portals: advaxis.com | facebook | twitter | LinkedIn

Company:	Advaxis Incorporated
Headquarters Address:	305 College Road East
	Princeton, NJ 08540
Main Telephone:	609.452.9813
Website:	www.advaxis.com
Ticker:	ADXS(OTCBB)
Type of Organization:	Public
Industry:	Biotechnology
Key Executives:	Chairman: Thomas A Moore
	CFO: Mark J Rosenblum
	Executive Director: Conrad F Mir
Business Development
Contact:	Conrad Mir
Phone:	609.452.9813
Email:	[e-mail]